UBS Group’s Axcella Health Inc. Common Stock AXLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-106
| Closed | -$1.11K | – | 10562 |
|
|
2023
Q3 | $1.11K | Buy |
106
+70
| +194% | +$551 | ﹤0.01% | 8100 |
|
|
2023
Q2 | $196 | Sell |
36
-213
| -86% | -$2K | ﹤0.01% | 8404 |
|
|
2023
Q1 | $2.98K | Buy |
+249
| New | +$3.32K | ﹤0.01% | 8406 |
|
|
2022
Q4 | – | Sell |
-125
| Closed | -$5K | – | 11440 |
|
|
2022
Q3 | $5K | Sell |
125
-97
| -44% | -$5.16K | ﹤0.01% | 9272 |
|
|
2022
Q2 | $11K | Buy |
222
+97
| +78% | +$4.77K | ﹤0.01% | 7897 |
|
|
2022
Q1 | $8K | Buy |
125
+51
| +69% | +$2.55K | ﹤0.01% | 8747 |
|
|
2021
Q4 | $4K | Sell |
74
-152
| -67% | -$10.7K | ﹤0.01% | 9583 |
|
|
2021
Q3 | $16K | Sell |
226
-45
| -17% | -$3.85K | ﹤0.01% | 7450 |
|
|
2021
Q2 | $27K | Sell |
271
-38
| -12% | -$3.77K | ﹤0.01% | 7054 |
|
|
2021
Q1 | $37K | Buy |
309
+191
| +162% | +$26.9K | ﹤0.01% | 6838 |
|
|
2020
Q4 | $15K | Buy |
118
+63
| +115% | +$8.09K | ﹤0.01% | 7185 |
|
|
2020
Q3 | $6K | Sell |
55
-70
| -56% | -$8.63K | ﹤0.01% | 7253 |
|
|
2020
Q2 | $17K | Sell |
125
-237
| -65% | -$29K | ﹤0.01% | 6667 |
|
|
2020
Q1 | $31K | Sell |
362
-401
| -53% | -$41.1K | ﹤0.01% | 6193 |
|
|
2019
Q4 | $76K | Buy |
763
+703
| +1,172% | +$77.3K | ﹤0.01% | 6134 |
|
|
2019
Q3 | $9K | Sell |
60
-6
| -9% | -$1.11K | ﹤0.01% | 7235 |
|
|
2019
Q2 | $15K | Buy |
+66
| New | +$20.9K | ﹤0.01% | 6823 |
|
Other funds holding AXLA
UBS Group's AXLA Position: Q4 2023 in Review
UBS Group sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 106 shares — an estimated $1.11K sold.
UBS Group first reported a position in AXLA in Q2 2019 and held it in 17 quarters. The position peaked at $76K in Q4 2019. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.
- UBS Group reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- UBS Group sold 106 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $1.11K.
- UBS Group first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 17 quarters.
- UBS Group's Axcella Health Inc. Common Stock position peaked at $76K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.